Prazosin inhibits spontaneous locomotor activity in diabetic mice

Pharmacology Biochemistry and Behavior

Volumn 72, Issue 1-2, 2002, Pages 365-369

  Saitoh, Akiyoshi ^a   Onodera, Kenji ^b   Morita, Kayo ^a   Sodeyama, Midori ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

1 Adrenoceptor antagonist; Diabetic mice; Prazosin; Spontaneous locomotor activity

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; PRAZOSIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; FOREBRAIN; LIMBIC CORTEX; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RECEPTOR BLOCKING; STREPTOZOCIN DIABETES; TURNOVER TIME; ANIMAL; COMPARATIVE STUDY; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; INSTITUTE FOR CANCER RESEARCH MOUSE; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0036202649     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00766-3     Document Type: Article

References (23)

1. Diabetes-induced alteration in brain monoamine metabolism in rats
2. Spinal cord noradrenergic dynamics in diabetic and hypercortisolaemic states
3. 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection
4. Importance of the noradrenaline-dopamine coupling in the locomotor activation effects of D-amphetamine
5. 2-Adrenoreceptor antagonists differentially influence locomotor and stereotyped behavior induced by D-amphetamine and apomorphine in the rat
6. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients
7. Enhancing effect of methamphetamine on ambulatory activity produced by repeated administration in mice
8. Depression and bipolar disorder: Relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, aging and osteoporosis
9. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
10. Role of noradrenergic function in the modification of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes
11. Involvement of dopamine D2 receptor-mediated function in the modulation of morphine-induced antinociception in diabetic mouse
12. Modification of effects of 7-OH-DPAT, a dopamine D3-receptor agonist, on morphine-induced hyperlocomotion by diabetes
13. Role of spleen or spleen products in the reduced locomotor-enhancing effect of morphine in diabetic mice
14. Evidence for the modulation of spontaneous locomotor activity by higher serum glucose levels and/or spleen-derived factor(s) in diabetic mice
15. Effects of diabetes on spontaneous locomotor activity in mice
16. Modification of m-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes
17. Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis
18. Dopamine receptor binding is increased in diabetic rats
19. Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens
20. Prevalence of major depression, simple phobia, and other psychiatric disorders in patients with long-standing type I diabetes mellitus
21. 1 receptor-mediated locomotor-enhancing activity in mice
22. Effects of prazosin on the dopaminergic neurotransmission in rat brain
23. Influence of streptozotocin diabetes on the alpha-a adrenoceptor and associated G proteins in rat arteries